MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT07677475 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07677475
- Sponsor
- Dongguan People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2029-01-30
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.